GAG Bioscience, of Bremen, Germany, has plans to import its scrapie-susceptibility testing business to Canada, and introduce its floundering beef-traceability unit to North American and European markets. But the company may first need to obtain certain intellectual property rights owned by Sequenom, SNPtech Pharmacogenomics Reporter has learned.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.